Emma Du Four is Head of International Regulatory Policy at AbbVie. She leads a team providing strategic guidance on key regulatory policy issues and external advocacy in support of access for patients to innovative medicines.

Emma has an honours degree in Biochemistry, a Masters degree in Business Administration and is a Fellow of the organisation for professionals in regulatory affairs. She partners with an extensive external network of industry, government, academic and healthcare system partners and has a broad range of experience across all aspects of innovative medicines development. Specific areas of expertise include policy & strategy development, clinical trials, biotechnology, real world evidence, pharmacovigilance, paediatric drug development and Brexit.

Emma regularly represents AbbVie and industry on scientific and technical issues. She is Vice Chair of the BIA Regulatory Advisory Committee and the EFPIA European Regulatory Expert Group. She has been influential in shaping the current regulatory environment and is a recognised expert in her field.